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Abstract
Background
High blood pressure is a major risk factor for the development and rupture of cerebral aneu-
rysm. Endovascular coil embolization and surgical clipping are established procedures to
treat cerebral aneurysm. However, longitudinal data of blood pressure after the treatment of
cerebral aneurysm and its impact on long-term prognosis are not well known.
Methods
This retrospective cohort study included 1275 patients who underwent endovascular coil
embolization (n = 558) or surgical clipping (n = 717) of cerebral aneurysm in 2002–2015
using the nationwide health screening database of Korea. Systolic and diastolic blood pres-
sure of patients were repeatedly obtained from the nationwide health screening program.
We performed a multivariate time-dependent Cox regression analysis of the primary com-
posite outcome of stroke, myocardial infarction, and all-cause death.
Results
During the mean follow-up period of 6.13 ± 3.41 years, 89 patients suffered the primary out-
come. Among the total 3546 times of blood pressure measurement, uncontrolled high blood
pressure (systolic�140 mmHg or diastolic�90 mmHg) was 22.9%. There was a signifi-
cantly increased risk of primary outcome with high systolic (adjusted HR [95% CI] per 10
mmHg, 1.16 [1.01–1.35]) and diastolic (adjusted HR [95% CI] per 10 mmHg, 1.32 [1.06–
1.64]) blood pressure.
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Conclusions
High blood pressure is prevalent even in patients who received treatment for cerebral aneu-
rysm, which is significantly associated with poor outcome. Strict control of high blood pres-
sure may further improve the prognosis of patients with cerebral aneurysm.
Introduction
Cerebral aneurysm, an abnormal focal dilation or ballooning of the intracranial cerebral artery
wall, occurs in about 1–5% of the general population [1]. Although most cases of cerebral
aneurysm are asymptomatic, some are susceptible to further dilatation and rupture resulting
in subarachnoid hemorrhage (SAH), a life-threatening stroke [2]. Because nontraumatic SAH
is mostly caused by the rupture of cerebral aneurysms, the management strategy for cerebral
aneurysm to reduce the worldwide health burden of SAH is clinically challenging. Endovascu-
lar coil embolization and surgical clipping are two established treatments for ruptured and
unruptured cerebral aneurysm [3, 4]. Beyond the interventions, the control of risk factors is
also desirable for high-risk patients with cerebral aneurysm [5].
Hypertension is recognized as a major risk factor for the development, enlargement, and
rupture of cerebral aneurysm [6]. Hemodynamic stress and inflammation induced by high
blood pressure could lead to arterial wall damage and dilation, resulting in the growth and rup-
ture of cerebral aneurysm [1, 7]. Therefore, strict control of blood pressure is considered essen-
tial in the management of cerebral aneurysm [5]. However, evidence for the relationship
between blood pressure and prognosis in patients with cerebral aneurysm are insufficient,
especially in those who underwent coil embolization or surgical clipping. The aims of this
study are to 1) obtain the longitudinal data of blood pressure after treatment of cerebral aneu-
rysm in real-world patients; and 2) evaluate the impact of longitudinal blood pressure on long-
term prognosis using data from the nationwide health screening database in Korea.
Materials and methods
Study design and data source
This retrospective cohort study used data from the National Health Insurance Service-National
Health Screening Cohort (NHIS-HEALS) in Korea [8]. The NHIS offers free nationwide
health examination program to all members� 40 years old every 2 years. The NHIS-HEALS
database included 541,866 individuals, comprising a random selection of 10% of all health
screening participants aged 40–79 years old in 2002 and 2003. It contains serial information
about health examinations in 2002–2015 including physical examinations for blood pressure
and body mass index (BMI) and questionnaires of medical history and lifestyle. It also includes
individuals’ health claim data about hospital visits, medical procedures, diagnosis, and drug
prescriptions in 2002–2015. Any diagnosis made at each hospital visit was recorded according
to the International Statistical Classification of Diseases and Related Health Problems 10th
Revision (ICD-10). The NHIS-HEALS data were fully de-identified and anonymized for all
analyses.
Study patients
Based on the health claim codes in the NHIS-HEALS, we selected patients who underwent
endovascular coil embolization (M1661, M1662) or surgical clipping (S4641, S4642) for
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the treatment of cerebral aneurysm in 2002–2015 [9]. Among them, we only included
patients with at least one available data of systolic and diastolic blood pressure (SBP and
DBP, respectively) from the nationwide health examination program after the index date
of cerebral aneurysm treatment (admission date for coil embolization or surgical clipping)
and before the study end date (date of death, development of primary outcome, loss of eli-
gibility for NHIS due to emigration, or Dec 31, 2015, whichever occurred the earliest). A
flow chart of the patient inclusion process is shown in Fig 1. This study was approved, and
informed consent was waived by the Institutional Review Board of Bundang CHA Medical
Center (CHAMC 2018-05-011) due to the retrospective nature of the study and use of de-
identified data.
Fig 1. Flow chart of patient inclusion process. NHIS-HEALS, National Health Insurance Service-National Health Screening Cohort in Korea.
https://doi.org/10.1371/journal.pone.0252042.g001
PLOS ONE BP and prognosis of treated cerebral aneurysm
PLOS ONE | https://doi.org/10.1371/journal.pone.0252042 May 27, 2021 3 / 15
Measure of blood pressure
Since the health screening program was recommended every 2 years, we were able to obtain
longitudinal data of blood pressure of the study patients. According to the protocol, SBP and
DBP were measured by qualified medical personnel at the brachial artery after a 5-minute rest
in the sitting position using a cuff of appropriate size [10, 11]. Both automated oscillometric
devices and mercury sphygmomanometers were used for blood pressure measurements. The
choice of blood pressure measurement devices was left to the discretion of individual health
examination centers. More information on blood pressure measurements during health
check-ups in Korea is available in the reference [10]. In the analysis, we treated blood pressures
as: 1) continuous variables (per 10 mmHg); and 2) categorical variables (SBP:�119, 120–129,
130–139, 140–149,�150 mmHg; DBP:�69, 70–79, 80–89, 90–99,�100 mmHg). In the cate-
gorical analysis, the most frequent categories of SBP (130–139 mmHg) and DBP (80–89
mmHg) were set as the references.
Study outcomes
The primary outcome was defined as the composites of stroke, myocardial infarction (MI),
and all-cause mortality, whichever occurred first. The development of stroke was defined as
admission with a primary diagnosis of I60–I64 (hemorrhagic, I60–I62; ischemic, I63; not spec-
ified, I64) and the completion of brain computed tomography or magnetic resonance imaging
during the admission period [9, 12, 13]. MI was defined as admission with a primary diagnosis
of I21 [14]. The diagnostic accuracy of stroke and MI based on the health claim records in the
NHIS was validated in prior studies [15, 16]. Each patient’s date of death available in the
NHIS-HEALS was linked with Statistics Korea.
Covariates
Data on sex, treatment modality of cerebral aneurysm (coil embolization or surgical clipping),
and age at treatment were collected. The treatments for ruptured and non-ruptured aneurysm
were determined by the presence of the diagnostic code of nontraumatic SAH (I60) before or at
the index date [9]. Based on the prescription claims data of individual patient, the use of antihy-
pertensive medication was determined whether or not the patient was prescribed oral antihy-
pertensive medications (any of calcium channel blocker, angiotensin-converting enzyme
inhibitor, angiotensin receptor blocker, diuretics, and β-blocker) at the day of health examina-
tion. The self-administered questionnaire in the health examination included questions regard-
ing lifestyle factors including current smoking status, alcohol consumption, and physical
activity [8, 17]. If patients had a fasting blood glucose level� 126 mg/dL or answered “yes” in
the corresponding health screening questionnaire about the diagnosis of diabetes mellitus
(DM), the patients were considered to have DM [18]. BMI was calculated by dividing weight by
height squared as a continuous variable (kg/m2). Along with SBP and DBP, the data obtained
from the repeatedly health examination program were treated as time-dependent covariates.
Statistical analysis
The collected data were expressed as number (%) for categorical variables and
mean ± standard deviation for continuous variables. We performed time-dependent Cox pro-
portional hazard regression analysis for the primary outcome. Due to the high correlation
between SBP and DBP, two individual models with SBP and DBP were constructed. In the
Cox regression model, repeatedly measured data at the health screening examination includ-
ing blood pressure were treated as time-dependent variables. The proportional hazards
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assumption for systolic/diastolic blood pressure in the Cox models was tested by calculating
the Schoenfeld residuals, which was found to be satisfactory. In the multivariate models,
adjustments were made for sex, age, treatment modality for cerebral aneurysm (coil emboliza-
tion or surgical clipping), ruptured versus unruptured cerebral aneurysm, antihypertensive
medication, the presence of DM, BMI, current smoking, physical activity, and alcohol con-
sumption. We illustrated curves for the estimated risk with the continuous value of blood pres-
sure using the restricted cubic spline method. In the secondary outcome analyses, we
constructed cause-specific Cox regression models that had stroke, MI, and all-cause mortality
as events of interest (each event serves as a competing risk). Data manipulation and statistical
analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC, USA) and R software
version 3.3.3 (The R Foundation for Statistical Computing, Vienna, Austria; http://www.R-
project.org/). Two-sided values of p<0.05 was considered statistically significant.
Results
Clinical characteristics
According to the inclusion criteria (Fig 1), we finally included 1275 patients who underwent
endovascular coil embolization (n = 558) and surgical clipping (n = 717). Among the included
patients, 33.5% were male and the mean age at treatment was 59.4 ± 8.1 years. The patients’
clinical characteristics are shown in Table 1.
Distribution of blood pressure during follow-up
After treatment, mean follow-up duration was 6.13 ± 3.41 years. During the study period,
there were a total of 3546 blood pressure measurements. The median number of blood pres-
sure measurements per patient was 2 (interquartile range, 1–4). Among the included patients,
the mean ± standard deviation time of the first and last health examination were 1.67 ± 1.57
years and 4.92 ± 3.35 years, respectively. We assessed blood pressure according to the time
period since treatment for cerebral aneurysm. Fig 2 shows the distribution of blood pressure
categories for each yearly blood pressure measurement (per 1-year interval).
Regardless of the time of measurement after the treatment for cerebral aneurysm, about
15–20% of patients had an SBP� 140 mmHg and about 12–20% of patients had a DBP� 90
mmHg among the patients who underwent blood pressure measurements at the time intervals.
When we defined uncontrolled high blood pressure as either SBP� 140 mmHg or DBP� 90
mmHg, the proportion was 22.9% among the total 3546 times of blood pressure measurement
in this study [19].
Risk for primary outcome according to blood pressure
During the study period, 89 patients had the primary outcome (stroke, MI, all-cause death con-
sidering only the earliest event). In the univariate and multivariate Cox regression models, high
SBP and DBP were significantly associated with increased risk of the primary outcome (Table 2).
When blood pressures were treated as continuous variables, adjusted hazard ratio (HR) [95%
confidence interval (CI)] for primary outcome per 10 mmHg increase in SBP and DBP were 1.16
[1.01–1.35] and 1.32 [1.06–1.64], respectively. There was no significant interaction effect between
blood pressure and antihypertensive medication on the risk for primary outcome (p-value for
interaction between systolic blood pressure and antihypertensive medication = 0.477, p-value for
interaction between diastolic blood pressure and antihypertensive medication = 0.808).
Fig 3 illustrates a spline curve for HR according to blood pressure. In the spline curves, risk
of the primary outcome seems to increase with SBP> 130 mmHg and DBP > 80 mmHg.
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In the analysis of blood pressure categories (Table 2), groups with high blood pressure were
positively associated with risk of the primary outcome. Compared to SBP of 130–139 mmHg
(reference), SBP of 140–149 mmHg (adjusted HR, 2.41; 95% CI, 1.18–4.94) and SBP� 150
mmHg (adjusted HR, 3.78; 95% CI, 1.93–7.42) were at significantly increased risk of the pri-
mary outcome. Interestingly, there was an increased risk at an SBP� 119 mmHg (adjusted
HR, 2.04; 95% CI, 1.09–3.83) compared to an SBP of 130–139 mmHg, suggesting a J-shaped
curve relationship. In the analysis of the DBP category, the risk of primary outcome increased
in proportion to the DBP. Compared to the reference (DBP 80–89 mmHg), adjusted HR [95%
CI] for DBP of 90–99 mmHg and�100 mmHg were 2.68 [1.47–4.89] and 2.92 [1.28–6.69],
respectively. For DBP, the J-shaped curve relationship was not significant.
Secondary outcome analysis
In the secondary outcome analysis for individual outcomes (Table 3), both high SBP and DBP
were significantly associated with increased risk of all stroke (I60–I64) after cerebral aneurysm
treatment. A high DBP was an independent risk factor for hemorrhagic stroke (I60–I62;
Table 1. Clinical characteristics of included patients.
Variable All patients Ruptured Non-ruptured p-value†
Number of included patients 1275 551 724 -
Total number of health examinations 3546 1825 1721 -
Variables at treatment of cerebral aneurysm
Sex, male 427 (33.5) 193 (35.0) 234 (32.3) <0.001
Age, years 59.4 ± 8.1 57.0 ± 8.1 61.3 ± 7.6 <0.001
Treatment modality <0.001
Surgical clipping 717 (56.2) 378 (68.6) 339 (46.8)
Coil embolization 558 (43.8) 173 (31.4) 385 (53.2)
Cerebral aneurysm -
Ruptured 551 (43.2) 551 (100) -
Non-ruptured 724 (56.8) - 724 (100)
Variables at first health examination after cerebral aneurysm treatment �
Systolic blood pressure, mmHg 127.1 ± 14.7 128.9 ± 14.6 125.7 ± 14.6 <0.001
Diastolic blood pressure, mmHg 78.5 ± 9.6 79.6 ± 9.9 77.6 ± 9.3 <0.001
Antihypertensive medication 653 (51.2) 268 (48.6) 385 (53.2) <0.121
Diabetes mellitus 262 (20.6) 92 (16.7) 170 (23.5) 0.004
Body mass index (kg/m2) 24.2 ± 2.9 24.1 ± 2.9 24.2 ± 2.9 0.551
Current smoking 108 (8.5) 50 (9.1) 58 (8.0) 0.566
Alcohol consumption, frequency per week <0.001
<1 time 787 (61.7) 382 (69.3) 405 (55.9)
1–2 times 403 (31.6) 142 (25.8) 261 (36.0)
3–4 times 63 (4.9) 19 (3.4) 44 (6.1)
�5 times 22 (1.7) 8 (1.5) 14 (1.9)
Exercise, days per week 0.257
<1 day 648 (50.8) 291 (52.8) 357 (49.3)
1–3 days 365 (28.6) 158 (28.7) 207 (28.6)
�5 days 262 (20.6) 102 (18.5) 160 (22.1)
Data are represented as number of patients (%) or mean ± standard deviation.
�Treated as time-dependent covariates in the survival analysis.
†p-value are derived by chi-square test or independent t-test between groups with ruptured and non-ruptured aneurysm.
https://doi.org/10.1371/journal.pone.0252042.t001
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adjusted HR, 1.56; 95% CI, 1.11–2.20). The risk of hemorrhagic stroke was also positively (but
not significantly) associated with high SBP (adjusted HR, 1.21; 95% CI, 0.97–1.52).
Fig 2. Distribution of blood pressure according to the time from the treatment of cerebral aneurysm. Proportion of
category by (A) systolic blood pressure and (B) diastolic blood pressure among patients who underwent a health
examination at each time period since the treatment for cerebral aneurysm. The bar between years 1 and 2 (x-axis)
indicates the distribution of blood pressure categories among the patients who underwent a health examination at 1–2
years after treatment for cerebral aneurysm. �Number of blood pressure measurements during the time period. BP, blood
pressure (mmHg); DBP, diastolic blood pressure; SBP, systolic blood pressure.
https://doi.org/10.1371/journal.pone.0252042.g002
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Sensitivity analysis
To investigate the potential interaction effects between high blood pressure and other risk fac-
tors, we performed a subgroup analysis according to the presence of individual risk factors
(Fig 4). In the subgroup analysis, we found no significant interaction between SBP/DBP and
any other risk factors.
Comparison of included and excluded patients according to the available
data of health examination after the treatment
In current study, we only included patients who underwent at least one health examination
program. To evaluate the difference of prognosis in the included and excluded patients accord-
ing to availability of health examination data (Fig 1), we compared the primary outcome
between the groups (Table 4). In the comparison, there was significantly increased risk for pri-
mary outcome in the excluded patients who did not receive health examination after the treat-
ment than included patients.
Discussion
The current study evaluated real-world data of longitudinal blood pressure after the treatment
of cerebral aneurysm and the relationship with clinical outcome using data from the nation-
wide health screening database. We found that high blood pressure was prevalent even in
patients with cerebral aneurysm who underwent coil embolization or clipping. Our finding is
in line with those of prior epidemiologic studies showing that blood pressure control is fre-
quently insufficient in clinical practice regardless of general or disease-specific populations
[20–22]. The prevalent feature of high blood pressure showed clear adverse effects on long-
Table 2. Effects of blood pressure on primary outcome after aneurysm treatment.
Crude HR [95% CI] Adjusted HR [95% CI]
SBP as continuous variable, per 10 mmHg 1.19 [1.04–1.36] 1.16 [1.01–1.35]
SBP as categorical variable, mmHg
�119 1.95 [1.05–3.60] 2.04 [1.09–3.83]
120–129 0.97 [0.47–2.01] 1.00 [0.48–2.12]
130–139 Ref Ref
140–149 2.49 [1.23–5.05] 2.41 [1.18–4.94]
�150 3.86 [1.95–7.64] 3.78 [1.93–7.42]
DBP as continuous variable, per 10 mmHg 1.30 [1.06–1.59] 1.32 [1.06–1.64]
DBP as categorical variable, mmHg
�69 1.23 [0.59–2.56] 1.18 [0.57–2.46]
70–79 1.27 [0.74–2.17] 1.28 [0.75–2.17]
80–89 Ref Ref
90–99 2.39 [1.30–4.39] 2.68 [1.47–4.89]
�100 2.87 [1.24–6.64] 2.92 [1.28–6.69]
Data are derived from time-dependent Cox proportional hazard regression models. Primary outcome is a composite
of stroke, myocardial infarction, and all-cause death. Adjustment was done for sex, age, coil embolization/surgical
clipping, ruptured/unruptured cerebral aneurysm, the presence of diabetes mellitus, antihypertensive medication,
body mass index, current smoking, physical activity, and alcohol consumption. Abbreviations: CI, confidence
interval; DBP, diastolic blood pressure; HR, hazard ratio; SBP, systolic blood pressure.
https://doi.org/10.1371/journal.pone.0252042.t002
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term prognosis. These findings suggest that more attention should be paid to achieving opti-
mal longitudinal blood pressure control after treatment for cerebral aneurysm.
Inadequate blood pressure control is a multifactorial problem that includes unawareness of
hypertension, inaccurate measurements, nonadherence to antihypertensive medications, sub-
optimal therapeutic goal creation, low socioeconomic status, environmental factors, health
care system issues, unhealthy lifestyles, excessive salt consumption, cultural and behavioral
influences, and other factors [23]. For better control of blood pressure, a multilevel systemic
Fig 3. Spline curves of the association between blood pressure and risk of primary outcome. Hazard ratio and 95% confidence interval for (A) SBP
and (B) DBP are presented with solid lines and shaded areas. The data are derived from time-dependent Cox proportional hazard regression model for
primary outcome using the method of restricted cubic splines with knots at 110, 120, 130, 140, and 150 mmHg of SBP and at 60, 70, 80, 90, and 100
mmHg of DBP. The reference is SBP 130 mmHg and DBP 80 mmHg. DBP, diastolic blood pressure; SBP, systolic blood pressure.
https://doi.org/10.1371/journal.pone.0252042.g003
Table 3. Secondary outcome analysis of individual outcomes by blood pressure after aneurysm treatment.
Secondary outcome (number of
events)
Adjusted HR [95% CI] per 10 mmHg
of SBP
Adjusted HR [95% CI] per 10 mmHg
of DBP
All stroke (n = 57)� 1.22 [1.02–1.47] 1.40 [1.07–1.84]
Hemorrhagic stroke (n = 33) 1.21 [0.97–1.52] 1.56 [1.11–2.20]
Ischemic stroke (n = 21) 1.29 [0.94–1.76] 1.24 [0.76–2.01]
Myocardial infarction (n = 6) 1.16 [0.78–1.73] 0.72 [0.36–1.43]
All-cause death (n = 26) 1.06 [0.79–1.41] 1.31 [0.88–1.97]
Models are adjusted for sex, age, coil embolization/surgical clipping, ruptured/unruptured cerebral aneurysm, the
presence of diabetes mellitus, antihypertensive medication, body mass index, current smoking, physical activity, and
alcohol consumption.
�All stroke is defined as hemorrhagic stroke (I60–I62), ischemic stroke (I63), and stroke not specified as hemorrhage
or infarction (I64) according to the International Classification of Diseases 10th Revision. Abbreviations: CI,
confidence interval; HR, hazard ratio.
https://doi.org/10.1371/journal.pone.0252042.t003
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approach is recommended, such as enhancing awareness and monitoring blood pressure,
implementing healthy lifestyle choices, and improving motivation and adherence to antihyper-
tensive medications [24]. We previously reported that poor adherence to antihypertensive
medication was significantly associated with poor prognosis of patients treated for cerebral
aneurysm and those with SAH [9, 12].
Fig 4. Effect of blood pressure on primary outcome by subgroup. Data are HR and 95% CI for (A) SBP and (B) DBP derived from time-
dependent Cox proportional hazard regression model for primary outcome. �p-value for interaction between risk factor and blood pressure. CI,
confidence interval; DBP, diastolic blood pressure; HR, hazard ratio; SBP, systolic blood pressure.
https://doi.org/10.1371/journal.pone.0252042.g004
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There are conflicting epidemiological reports of the relationship between hypertension and
cerebral aneurysm, but a large proportion of data support the important role of high blood
pressure on the development and prognosis of cerebral aneurysm [3, 5, 25]. In a case-control
study of 20,767 Medicare patients, the prevalence of hypertension was significantly higher in
patients with unruptured cerebral aneurysms compared to a control population (43.2% vs
34.4%, respectively) [26]. Hypertension was more prevalent in those with multiple aneurysms
[27]. In a longitudinal follow-up computed tomography angiography study of 610 patients
who survived after SAH, the presence of hypertension was a significant risk factor for new
aneurysm formation and enlargement of the known aneurysm [28]. In the large population-
based prospective cohort study of 74,977 participants (Nord-Trøndelag Health study), there
was a strong positive association between high blood pressure (SBP and DBP) and risk of
aneurysmal SAH [6]. In the UIATS (unruptured intracranial aneurysm treatment score)
model developed as a decision guideline for the appropriate management of unruptured cere-
bral aneurysm, hypertension is a key factor favoring aneurysm repair due to a high risk of rup-
ture rather than conservative management [29]. Based on these epidemiologic evidence,
hypertension is recognized as an important modifiable risk factor for preventing cerebral
aneurysm rupture [5]. Furthermore, the presence of hypertension before SAH is a risk factor
for rebleeding and worse clinical outcome in the SAH patients [30]. Current guidelines for
cerebral aneurysm strongly recommend blood pressure monitoring to patients with cerebral
aneurysm, and those with high blood pressure should receive treatment for hypertension [5,
31, 32].
There are suggested mechanisms regarding how hypertension can play an important role in
aneurysmal SAH [32]. Exposure to chronic hypertension causes intimal thickening, necrosis
of the tunica media, vascular inflammation, changes in the compositional matrix, and degener-
ation of the elastic lamina of the arterial wall, which lead to focal weakening and dilatation of
cerebral artery wall [33]. The increase in systemic blood pressure can directly lead to a simulta-
neous increase in intra-aneurysm blood pressure [34]. The normalization of blood pressure in
a mice model with aneurysm formation significantly reduced the risk of aneurysmal rupture
[7]. Beyond mechanical stress, activation of the local renin-angiotensin system and toll-like
receptor 4 pathway by systemic hypertension can induce vascular inflammation and remodel-
ing, contributing to aneurysm rupture [35]. Increased activity and imbalances of the metallo-
proteinase/tissue inhibitors of metalloproteinase system in hypertensive patients predisposes
them to cerebral aneurysm formation and growth [36, 37]. Hypertension also contributes to
disturbances in the brain nitric oxide synthase system, which participates in oxidative stress,
arterial damage, remodeling, and cerebral aneurysm formation and rupture [38].
The optimal blood pressure target among patients treated with cerebral aneurysm is
unknown. The updated American College of Cardiology/American Heart Association (ACC/
AHA) guidelines recommend strict blood pressure control (target of SBP< 130 mmHg and
DBP< 80 mmHg) in patients considered at high cardiovascular risk [39]. The 2018 European
Table 4. Comparison of the event outcome between included and excluded patients according to availability of health examination data after treatment to cerebral
aneurysm.
Group Number of patients Patient-years at risk Number of events� p-value†
Included patients (study participants) 1275 7816 89 <0.001
Excluded patients due to no available data of health screening 933 989 589
�composite of stroke, myocardial infarction, and all-cause death.
† p-value derived by log-rank test.
https://doi.org/10.1371/journal.pone.0252042.t004
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Society of Cardiology and European Society of Hypertension (ESC/ESH) guidelines on the
management of hypertension also recommended that the treated blood pressure values should
be targeted to 130/80mmHg or lower in most patients [40]. Unfortunately, there is no specific
comment about the target blood pressure of patients with cerebral aneurysm in the ACC/AHA
and ESC/ESH guidelines. Our current study demonstrates that high SBP (� 140 mmHg) and
DBP (� 90 mmHg) significantly increase risk for primary outcomes compared to the reference
group (SBP 130–139 mmHg, DBP 80–89 mmHg). Therefore, we supposed that the target pres-
sure should be at least SBP< 140 mmHg and DBP < 90 mmHg considering the significantly
increased risk over those levels. Regarding the lowest risk around SBP of 130 mmHg and DBP
of 80 mmHg in our data, we supposed that the target of SBP of 130 mmHg and DBP of 80
mmHg recommended in the recent ACC/AHA and ESC/ESH hypertension guidelines for
those at high cardiovascular risk was reasonable for patients treated with cerebral aneurysm.
Interestingly, we found an increased risk in the category of SBP < 120 mmHg versus refer-
ence (J-curve phenomenon). The J-curve phenomenon is a controversial issue, but the phe-
nomenon have been reported in both observational and randomized trials among the general
population and patients with vascular disease [41–43]. The exact mechanism of the J-curve
risk pattern is not well known. As one suggested mechanism, some deteriorating conditions
(malignancy, infection, malnutrition, heart failure, etc.) are more frequently found in patients
with low blood pressure [44]. A predisposition to falling, decreased perfusion to vital organs,
or adverse events related to hypotension may increase an individual’s cardiovascular risk and
mortality [45]. The 2018 ESC/ESH hypertension guidelines against SBP targeted to< 120
mmHg in high-risk patients considering balance of benefit versus harm [40]. Although strict
blood pressure control is recommended for patients with cerebral aneurysm, considerable cau-
tion should be used to avoid hypotension.
Strengths and limitations
The present study has strengths and limitations. Because the NHIS is a single payer insurer in
Korea, we could include patients who underwent coil embolization or surgical clipping for
cerebral aneurysm in a nationwide population and evaluate the long-term prognosis of them.
The nationwide health screening examination is performed repeatedly, which enables the col-
lection of longitudinal data on blood pressure. Beyond the strengths, we should acknowledge
the several limitations of this study. First, given the limitation of retrospective observational
cohort, our study could not prove the efficacy of interventions of improving blood pressure
control in patients with cerebral aneurysm. Due to the lack of detailed clinical information
from the health screening database, we could not assess cerebral aneurysm characteristics
(size, location, morphology). In current study, there was a large number of excluded patients
who never attended a health examination program after treatment for cerebral aneurysm.
Early mortality or severe disability after treatment of cerebral aneurysm can limit participation
to the health examination program. Indeed, the excluded patients had significantly worse
prognosis than included patients. Therefore, it should be noted that the included patients may
have a selection bias and did not adequately represent the population who underwent treat-
ment to cerebral aneurysm. Despite the long-term follow-up, only a small number of patients
experienced clinical outcomes, which limited statistical power and further analysis of individ-
ual outcomes and interaction between covariates. The current study was based on patients
who underwent coil embolization or surgical clipping. The general application of our result to
all patients with cerebral aneurysm should be further evaluated. Although we assessed clinical
outcomes using the definitions validated in prior studies, the accuracy based on health claims
codes might be limited. Our study population was Korean patients. There might be differences
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in decision making to treat aneurysm and disease susceptibility with different genetic and eth-
nic populations. Therefore, our data must be interpreted with caution.
Conclusions
For patients with treated cerebral aneurysm, high SBP (� 140 mmHg) and DBP (� 90 mmHg)
were prevalent and significantly associated with worse clinical outcome. Regular monitoring
and strict control of blood pressure may improve the prognosis of the patients with treated
cerebral aneurysm.
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